首頁 > 市場調查報告書 > 醫療設備

e保健醫院 IT 電子海圖

市場調查報告書

商品編碼

1654653

全球電子健康記錄 (EHR) 市場 - 2025 至 2033 年

Global Electronic Health Records (EHR) Market - 2025-2033

出版日期: 2025年02月13日 | 出版商:

DataM Intelligence | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球電子健康記錄 (EHR) 市場規模達到 329.7 億美元，預計到 2033 年將達到 507.8 億美元，在 2025-2033 年預測期內的複合年成長率為 3.8%。

電子健康記錄 (EHR) 是有關個人的醫療資訊的數位集合，包括診斷、藥物、測試、過敏、免疫接種和治療計劃。它儲存在電腦上，所有醫療保健提供者都可以訪問，從而使他們能夠對患者的護理提出建議。 EHR 也稱為電子病歷。

市場動態：

促進因素與約束因素

政府措施和監管要求增多

政府措施和監管要求正在推動全球採用電子健康記錄 (EHR)，以提高效率、資料可近性和患者治療效果。美國的《HITECH法案》為經過認證的EHR系統提供財政激勵，而歐洲健康資料空間（EHDS）則專注於資料互通性和跨境醫療服務。發展中地區正在投資數位基礎設施，以實現醫療保健系統的現代化，從而進一步擴大 EHR 市場。監管架構要求資料隱私、安全性和報告合規性，確保 EHR 系統安全有效地實施。這些措施促進了創新並改善了全球醫療保健服務。

例如，2024 年 4 月，印度衛生部推出了適用於 iOS 設備的 myCGHS 應用程式，旨在改善中央政府健康計劃 (CGHS) 受益人對電子健康記錄、資訊和資源的存取。該應用程式由印度國家資訊中心 (NIC) 喜馬偕爾邦和 NIC 健康團隊開發，提供一系列健康服務，體現了政府對技術的承諾。

資料隱私和安全問題

全球電子健康記錄 (EHR) 市場因資料隱私和安全問題而面臨挑戰。 EHR 系統儲存敏感的患者訊息，使其容易受到網路攻擊和資料外洩。這些事件損害了患者的隱私並削弱了人們對數位醫療解決方案的信任。醫療保健組織面臨 HIPAA 和 GDPR 等法規的合規性問題，並且在保持安全性的同時管理跨境資料共享非常複雜。小型供應商可能難以實施強大的網路安全措施，從而阻止他們採用 EHR 系統。對先進安全協議、定期審計和培訓的投資可能會減緩 EHR 技術的採用。

Oracle Corporation
Veradigm LLC
MEDITECH
McKesson Corporation
GE Healthcare
NXGN Management, LLC
Athenahealth
eClinicalWorks
Greenway Health
Similar data will be provided for each market player.
醫學現代化
- 管道產品描述
- 產品關鍵績效指標 (KPI)
- 主要活動
- 市場進入時間表
- 產品滲透率
- 銷售估計和預測
關懷雲
卡雷奧
實踐融合
健康融合
將為每個市場參與者提供類似的資料。

第 13 章：附錄

簡介目錄

Product Code: HCIT9097

The Global Electronic Health Records (EHR) Market reached US$ 32.97 billion in 2024 and is expected to reach US$ 50.78 billion by 2033, growing at a CAGR of 3.8% during the forecast period 2025-2033.

An electronic health record (EHR) is a digital collection of medical information about a person, including diagnoses, medications, tests, allergies, immunizations, and treatment plans. It is stored on a computer and accessible to all healthcare providers, enabling them to make recommendations about the patient's care. EHRs are also known as electronic medical records.

Market Dynamics: Drivers & Restraints

Rise in Government Initiatives and Regulatory Mandates

Government initiatives and regulatory mandates are driving the global adoption of Electronic Health Records (EHR) to improve efficiency, data accessibility, and patient outcomes. The HITECH Act in the US offers financial incentives for certified EHR systems, while the European Health Data Space (EHDS) focuses on data interoperability and cross-border healthcare services. Developing regions are investing in digital infrastructure to modernize healthcare systems, further expanding the EHR market. Regulatory frameworks mandate data privacy, security, and reporting compliance, ensuring safe and effective implementation of EHR systems. These initiatives foster innovation and improve global healthcare delivery.

For instance, in April 2024, The Union Health Ministry has launched the myCGHS app for iOS devices, aiming to improve access to Electronic Health Records, information, and resources for beneficiaries of the Central Government Health Scheme (CGHS). The app, developed by the National Informatics Centre (NIC) Himachal Pradesh and NIC Health Team, offers a range of health services and demonstrates the government's commitment to technology.

Data Privacy and Security Concerns

The global Electronic Health Records (EHR) market faces challenges due to data privacy and security concerns. EHR systems store sensitive patient information, making them vulnerable to cyberattacks and data breaches. These incidents compromise patient privacy and erode trust in digital healthcare solutions. Healthcare organizations face compliance with regulations like HIPAA and GDPR, and managing cross-border data sharing while maintaining security is complex. Smaller providers may struggle to implement robust cybersecurity measures, deterring them from adopting EHR systems. Investment in advanced security protocols, regular audits, and training could slow the adoption of EHR technology.

Segment Analysis

The global Electronic Health Records (EHR) market is segmented based on Product Type, Component, Application, End User and Region.

Product Type:

Web/Cloud-based EHR segment is expected to dominate the Electronic Health Records (EHR) market share

The web/cloud-based segment holds a major portion of the electronic health records (EHR) market share and is expected to continue to hold a significant portion of the electronic health records (EHR) market share during the forecast period.

The global electronic health records market is growing due to the scalability, cost-effectiveness, and ease of deployment of web and cloud-based EHR systems. These solutions allow healthcare providers to access patient data in real-time, improving care coordination and decision-making. Cloud-based EHRs reduce upfront investments in hardware and IT infrastructure, making them attractive for small and medium-sized organizations. They facilitate interoperability and data sharing, critical for population health management and value-based care. The integration of advanced technologies like AI and machine learning enhances their functionality.

For instance, in October 2024, Oracle has introduced an AI-driven update to its EHR software, allowing it to operate in a speech-driven manner, allowing healthcare professionals more time to deliver care. The cloud-based EHR, which was acquired by Oracle for $28 billion in 2022, is not based on Cerner's technology, meaning existing Cerner clients will eventually have to switch to the new Oracle EHR. The AI-driven, cloud-based EHR aims to ease administrative burdens and improve patient care.

Application:-

Cardiology segment is the fastest-growing segment in Electronic Health Records (EHR) market share

The cardiology segment is the fastest-growing segment in the electronic health records (EHR) market share and is expected to hold the market share over the forecast period.

Cardiology applications are crucial in the global Electronic Health Records (EHR) market, addressing the complex needs of cardiovascular care. These modules manage cardiac patient data, including diagnostic imaging, test results, and treatment plans, enabling cardiologists to track patient progress and ensure adherence to clinical guidelines. The integration of advanced tools like real-time ECG monitoring, risk stratification analytics, and imaging interoperability enhances the efficiency of cardiovascular care. With the increasing prevalence of cardiovascular diseases, cardiology-focused EHR solutions are vital for improving patient outcomes, streamlining workflows, and supporting value-based care initiatives.

For instance, in July 2024, Intrahealth, a subsidiary of HEALWELL AI, has launched an AI-powered co-pilot for cardiologists exclusively powered by HEALWELL AI. The co-pilot aims to identify patients at high risk of cardiovascular disease, a significant advancement in healthcare technology, as well as a significant step towards enhancing care delivery.

Geographical Analysis

North America is expected to hold a significant position in the Electronic Health Records (EHR) market share

North America holds a substantial position in the electronic health records (EHR) market and is expected to hold most of the market share due to robust healthcare infrastructure and government initiatives. The HITECH Act and financial incentives have boosted adoption rates. The region also benefits from high healthcare IT spending, chronic disease prevalence, and patient-centric care. The integration of AI and cloud-based solutions in EHR systems further propels the market in North America.

For instance, in September 2024, Oracle Health is enhanced its electronic health record (EHR) technology to improve clinician efficiency and patient care. The company has invested in core clinical applications since the Cerner acquisition, enhancing performance, usability, and security. Oracle is committed to making its EHR functional and user-friendly, while also building a next-generation platform leveraging Oracle Cloud Infrastructure's performance, security, and AI capabilities.

Europe is growing at the fastest pace in the Electronic Health Records (EHR) market

Europe holds the fastest pace in the electronic health records (EHR) market and is expected to hold most of the market share due to investments in digital health initiatives and government mandates for interoperable healthcare systems. Programs like EHDS and country-specific digital transformation plans support EHR adoption. The aging population and rising chronic diseases demand efficient healthcare data management. Europe's focus on cross-border healthcare services, data exchange, and advanced technologies like blockchain and AI contributes to market growth.

The German electronic patient record (ePA) was introduced on 15 January 2025 for all statutory insured persons who haven't opted out. However, a Civey survey by eco reveals that 65% of respondents didn't feel well informed about the ePA's introduction. Eco- Association of the Internet Industry believes that while the ePA has potential for improved patient care and more efficient healthware processes, it also emphasizes the need for public authorities and healthcare institutions to strengthen trust in digital health services.

Competitive Landscape

The major global players in the Electronic Health Records (EHR) market include Epic Systems Corporation, Oracle Corporation, Veradigm LLC, MEDITECH, McKesson Corporation, GE Healthcare, NXGN Management, LLC, Athenahealth, eClinicalWorks, Greenway Health and among others.

Key Developments

In January 2025, Samsung has integrated the Health Records feature into its Health app, allowing users to create and access their Ayushman Bharat Health Account (ABHA) directly through the Samsung Health Mobile App. This feature enables users to manage health data generated by healthcare providers across India, transforming the way individuals manage their personal health records.
In May 2024, Athenahealth has introduced new electronic health record products for specialists, aiming to reduce burnout and improve the EHR experience by combining critical capabilities with tailored workflows.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global electronic health records (EHR) market report delivers a detailed analysis with 62 key tables, more than 56 visually impactful figures, and 192 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Component & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Component
3.3. Snippet by Application
3.4. Snippet by End User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rise in Government Initiatives and Regulatory Mandates
- 4.1.2. Restraints
  - 4.1.2.1. Data Privacy and Security Concerns
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Web/Cloud-based EHR*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. On-premise EHR

7. By Component

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 7.1.2. Market Attractiveness Index, By Component
7.2. Software*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Hardware
7.4. Services

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Cardiology*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Neurology
8.4. Radiology
8.5. Oncology
8.6. Mental and Behavioral Health
8.7. Others

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Clinics
9.4. Ambulatory Surgical Centers
9.5. Specialty Centers
9.6. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. U.K.
  - 10.3.7.3. France
  - 10.3.7.4. Spain
  - 10.3.7.5. Italy
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. South Korea
  - 10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

Key Market Players

12.1. Epic Systems Corporation*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio
  - 12.1.2.1. Product Description
  - 12.1.2.2. Product Key Performance Indicators (KPIs)
  - 12.1.2.3. Historic and Forecasted Product Sales
  - 12.1.2.4. Product Sales Volume
- 12.1.3. Financial Overview
  - 12.1.3.1. Company Revenue's
  - 12.1.3.2. Geographical Revenue Shares
  - 12.1.3.3. Revenue Forecasts
- 12.1.4. Key Developments
  - 12.1.4.1. Mergers & Acquisitions
  - 12.1.4.2. Key Product Development Activities
  - 12.1.4.3. Regulatory Approvals etc.
- 12.1.5. SWOT Analysis
12.2. Oracle Corporation
12.3. Veradigm LLC
12.4. MEDITECH
12.5. McKesson Corporation
12.6. GE Healthcare
12.7. NXGN Management, LLC
12.8. Athenahealth
12.9. eClinicalWorks
12.10. Greenway Health
Similar data will be provided for each market player.

Emerging Market Players

12.11. Modernizing Medicine*
- 12.11.1. Pipeline Products Description
- 12.11.2. Product Key Performance Indicators (KPIs)
- 12.11.3. Key Activities
- 12.11.4. Market Entry Timelines
- 12.11.5. Product Penetration Rate
- 12.11.6. Sales Estimation and Projections
12.12. CareCloud
12.13. Kareo
12.14. Practice Fusion
12.15. HealthFusion
Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE